跳至主要内容
临床试验/NCT07676201
NCT07676201尚未招募不适用

One-year Prognostic Impact of Microcirculation Assessed by NH IMR Angio in Patients Hospitalized for Acute Myocarditis

University Hospital, Grenoble0 个研究点目标入组 106 人开始时间: 2026年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
106
主要终点
MACE

研究概览

简要总结

The goal of this observational study is to evaluate the association between post-coronary angiography IMR and medium-term clinical prognosis in patients with acute myocarditis. The main question it aims to answer is:

Is there a correlation between impaired microcirculation and the occurrence of serious clinical events in this population of patients?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients over the age of
  • Patients hospitalized between June 2015 and July
  • Patients who presented with chest pain and at least 1 diagnostic criterion; or, in the absence of chest pain, at least 2 of the following diagnostic criteria:
  • Electrocardiographic abnormalities (ST-segment elevation or depression, T-wave inversions, conduction disturbances such as type 3 atrioventricular block),
  • Elevated troponin levels,
  • Abnormal kinematics on echocardiography.
  • Associated with MRI findings of ≥2 tissue abnormalities (edema, hyperemia, myocardial fibrosis).
  • Coronary angiography performed during the initial hospitalization
  • Patient enrolled in or eligible for a social security program.
  • Patient who has expressed consent to participate.

排除标准

  • Absence of coronary artery disease confirmed by coronary angiography
  • Myocarditis secondary to immunotherapy
  • Presence of documented coronary artery disease (coronary angiography or cardiac CT)
  • Presence of cardiomyopathy (hypertrophic cardiomyopathy, dilated cardiomyopathy)
  • Infiltrative heart disease (sarcoidosis or cardiac amyloidosis)
  • Severe valvular heart disease
  • Takotsubo syndrome
  • Constrictive or chronic pericarditis
  • Loeffler's endocarditis
  • Left ventricular noncompaction
  • Cardiac tumor
  • Pulmonary embolism
  • Coronary spasm
  • Patients covered by Articles L1121-5 through L1121-8 of the Public Health Code (pregnant women, women in labor, and breastfeeding women; persons deprived of their liberty by judicial or administrative decision; adults under guardianship)

结局指标

主要结局

MACE

时间窗: From the time of the coronary angiography up to one year

The primary endpoint is the 1-year incidence rate of MACE. MACE is defined by a composite endpoint comprising: 1) all-cause mortality, 2) cardiac decompensation requiring readmission, 3) heart transplantation, 4) documented sustained ventricular arrhythmia lasting \>30 seconds, and 5) recurrence of myocarditis.

次要结局

  • Predictive value of MRI angiography: diagnostic performance in predicting the primary endpoint (ROC, optimal cut-off values, sensitivity/specificity)(From the time of the coronary angiography up to one year)
  • Assessment of inter- and intra-observer reproducibility of the MR angiography NH calculation (if a subsample is reanalyzed)(From the time of the coronary angiography up to one year)
  • Individual components of the 12-month MACE: cardiovascular death, transplantation, hospitalization for heart failure, and persistent heart failure (reported separately)(From the time of the coronary angiography up to one year)
  • Correlation between IMR angiographic NH (continuous variable) and: a) MRI imaging criteria (LVEF, fibrosis, septal involvement, edema); b) biological markers (maximum troponin, CRP)(From the time of the coronary angiography up to one year)

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

相似试验